These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34790437)

  • 1. Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.
    Bancroft EK; Raghallaigh HN; Page EC; Eeles RA
    Curr Genet Med Rep; 2021; 9(4):47-58. PubMed ID: 34790437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of prostate cancer: a review of latest evidence.
    Hall R; Bancroft E; Pashayan N; Kote-Jarai Z; Eeles RA
    J Med Genet; 2024 Sep; 61(10):915-926. PubMed ID: 39137963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
    Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
    J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer.
    Nguyen-Dumont T; Dowty JG; MacInnis RJ; Steen JA; Riaz M; Dugué PA; Renault AL; Hammet F; Mahmoodi M; Theys D; Tsimiklis H; Severi G; Bolton D; Lacaze P; Sebra R; Schadt E; McNeil J; Giles GG; Milne RL; Southey MC
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to prostate cancer: an update.
    Ni Raghallaigh H; Eeles R
    Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we recruit more men of African or African-Caribbean ancestry into our research? Co-creating a video to raise awareness of prostate cancer risk and the PROFILE study.
    Hainsworth E; McGrowder E; McHugh J; Bancroft E; Mahabir S; Webber W; Eeles R; Cruickshank S
    Res Involv Engagem; 2022 Apr; 8(1):14. PubMed ID: 35436967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
    Spain P; Carpenter WR; Talcott JA; Clark JA; Do YK; Hamilton RJ; Galanko JA; Jackman A; Godley PA
    Cancer; 2008 Oct; 113(8):2180-7. PubMed ID: 18798229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.
    Bancroft EK; Castro E; Bancroft GA; Ardern-Jones A; Moynihan C; Page E; Taylor N; Eeles RA; Rowley E; Cox K
    Psychooncology; 2015 Nov; 24(11):1492-9. PubMed ID: 25872100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
    McHugh J; Saunders EJ; Dadaev T; McGrowder E; Bancroft E; Kote-Jarai Z; Eeles R
    Br J Cancer; 2022 Jun; 126(10):1366-1373. PubMed ID: 34923574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
    Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
    Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.
    Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN
    Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
    Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
    Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer.
    Shoaibi A; Rao GA; Cai B; Rawl J; Haddock KS; Hébert JR
    Prostate; 2017 Feb; 77(2):173-184. PubMed ID: 27699819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.
    Saunders EJ; Kote-Jarai Z; Eeles RA
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Men with a susceptibility to prostate cancer and the role of genetic based screening.
    Eeles R; Ni Raghallaigh H
    Transl Androl Urol; 2018 Feb; 7(1):61-69. PubMed ID: 29594021
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.